Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1203
2.230
Why?
Carcinoma, Ductal, Breast
9
2015
91
1.470
Why?
Mastectomy, Segmental
8
2015
93
1.210
Why?
Catheter Ablation
4
2014
120
1.040
Why?
Neoplasm Recurrence, Local
7
2014
626
0.970
Why?
Sentinel Lymph Node Biopsy
15
2017
118
0.960
Why?
Mastectomy
10
2018
142
0.910
Why?
Mammary Neoplasms, Experimental
7
2010
121
0.820
Why?
Soybean Proteins
4
2023
161
0.800
Why?
Biopsy, Needle
11
2017
179
0.790
Why?
Obesity
8
2023
1123
0.780
Why?
Carcinoma in Situ
3
2008
73
0.750
Why?
Lymph Nodes
12
2017
257
0.730
Why?
Caseins
4
2023
78
0.720
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.700
Why?
Liver
9
2023
1133
0.650
Why?
DNA, Neoplasm
1
2018
144
0.570
Why?
Isoflavones
5
2023
89
0.570
Why?
Rats, Zucker
9
2023
68
0.510
Why?
Uterine Cervical Neoplasms
3
2007
276
0.470
Why?
Receptor, erbB-2
3
2018
74
0.460
Why?
Aged
32
2018
9770
0.450
Why?
Receptors, Estrogen
4
2018
132
0.440
Why?
Arginine
1
2015
187
0.430
Why?
Dietary Supplements
2
2015
450
0.430
Why?
Neoplasm Staging
15
2015
743
0.420
Why?
Female
51
2018
27188
0.420
Why?
Middle Aged
34
2018
12648
0.420
Why?
Mammary Neoplasms, Animal
2
2015
35
0.390
Why?
Diet
2
2015
564
0.390
Why?
Ultrasonography, Mammary
4
2015
61
0.370
Why?
Fatty Liver
3
2023
130
0.360
Why?
Carcinogens
3
2015
196
0.360
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.350
Why?
Benz(a)Anthracenes
1
2010
3
0.350
Why?
Dehydroepiandrosterone
1
2010
14
0.350
Why?
Rats
15
2023
3302
0.340
Why?
Axilla
9
2017
92
0.330
Why?
Aged, 80 and over
15
2018
3244
0.320
Why?
Lymphatic Vessels
4
2014
53
0.320
Why?
Adult
25
2018
13637
0.300
Why?
Prognosis
11
2017
1979
0.300
Why?
Plant Lectins
1
2008
8
0.300
Why?
Carcinoma, Ductal
1
2008
7
0.300
Why?
Magnetic Resonance Imaging
4
2014
1556
0.290
Why?
Humans
48
2024
50688
0.280
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.280
Why?
Receptors, Progesterone
4
2018
64
0.280
Why?
Electrosurgery
1
2007
8
0.270
Why?
Clinical Competence
2
2024
403
0.270
Why?
Lymphedema
5
2017
46
0.270
Why?
Thinness
3
2017
44
0.270
Why?
Lymphatic Metastasis
12
2015
222
0.260
Why?
Cytodiagnosis
4
2015
41
0.260
Why?
Animals
19
2023
13157
0.260
Why?
Prospective Studies
12
2017
2395
0.250
Why?
Follow-Up Studies
10
2015
2246
0.250
Why?
Nipples
5
2013
33
0.250
Why?
Combined Modality Therapy
5
2014
642
0.250
Why?
Biopsy, Fine-Needle
4
2024
109
0.240
Why?
Adenocarcinoma, Mucinous
1
2005
19
0.240
Why?
Endometritis
1
2004
5
0.230
Why?
Ethanol
5
2010
336
0.230
Why?
Competency-Based Education
1
2024
28
0.230
Why?
Proteoglycans
1
2004
81
0.220
Why?
Radiopharmaceuticals
6
2014
204
0.220
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
45
0.210
Why?
Proliferating Cell Nuclear Antigen
1
2003
68
0.210
Why?
Laser Coagulation
1
2003
26
0.210
Why?
Fellowships and Scholarships
1
2024
120
0.210
Why?
Membrane Glycoproteins
1
2004
246
0.210
Why?
Plasma Cells
1
2004
220
0.210
Why?
Lymph Node Excision
6
2017
131
0.200
Why?
Neoplasm Invasiveness
5
2015
269
0.200
Why?
Carcinoma, Lobular
3
2015
33
0.200
Why?
Coloring Agents
4
2014
67
0.200
Why?
Mammaplasty
2
2013
44
0.190
Why?
Uterine Cervical Dysplasia
3
2007
49
0.190
Why?
Infant Food
1
2002
28
0.190
Why?
Monitoring, Intraoperative
3
2014
54
0.180
Why?
Ovarian Neoplasms
1
2005
449
0.180
Why?
Immunohistochemistry
9
2017
958
0.170
Why?
Biopsy
4
2007
589
0.170
Why?
Ultrasonography, Interventional
3
2011
137
0.170
Why?
Paraffin Embedding
2
2018
51
0.160
Why?
Lung Neoplasms
3
2015
599
0.160
Why?
Body Weight
3
2017
517
0.160
Why?
Retrospective Studies
13
2015
6298
0.160
Why?
Sensitivity and Specificity
8
2015
861
0.160
Why?
Adolescent
8
2015
6489
0.160
Why?
Neoplasm Grading
3
2014
122
0.160
Why?
Tissue Fixation
1
2018
35
0.150
Why?
Specimen Handling
1
2018
55
0.150
Why?
Alanine Transaminase
3
2015
119
0.150
Why?
Rats, Sprague-Dawley
7
2015
1589
0.130
Why?
Treatment Outcome
5
2017
5296
0.130
Why?
Pulmonary Medicine
1
2015
15
0.120
Why?
Protein Hydrolysates
1
2015
6
0.120
Why?
Kaplan-Meier Estimate
2
2014
463
0.120
Why?
Aspartate Aminotransferases
1
2015
43
0.120
Why?
Plant Extracts
1
2017
175
0.120
Why?
Rosaniline Dyes
1
2014
8
0.120
Why?
Sulfotransferases
1
2015
39
0.120
Why?
Image-Guided Biopsy
1
2015
33
0.120
Why?
Dermatologic Surgical Procedures
2
2013
35
0.120
Why?
Melanoma
2
2011
280
0.110
Why?
Vacuum
2
2011
13
0.110
Why?
Young Adult
6
2015
4114
0.110
Why?
Interleukin-6
1
2015
261
0.110
Why?
Ultrasonography, Doppler
1
2014
41
0.110
Why?
Tumor Necrosis Factor-alpha
1
2015
393
0.110
Why?
Patient Care Planning
1
2013
66
0.110
Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.100
Why?
Intraoperative Care
2
2011
52
0.100
Why?
Disease-Free Survival
1
2014
442
0.100
Why?
Preoperative Care
1
2014
170
0.100
Why?
Skin Neoplasms
2
2011
496
0.100
Why?
Lymphography
1
2011
9
0.090
Why?
Image Processing, Computer-Assisted
2
2003
246
0.090
Why?
Frozen Sections
1
2011
13
0.090
Why?
Liver Neoplasms
2
2005
328
0.090
Why?
DNA Methylation
1
2015
549
0.090
Why?
Male
10
2023
25998
0.090
Why?
Cytoprotection
1
2010
34
0.090
Why?
Fatty Liver, Alcoholic
1
2010
7
0.080
Why?
Drug Evaluation, Preclinical
1
2010
144
0.080
Why?
Genistein
1
2010
46
0.080
Why?
Feasibility Studies
1
2011
389
0.080
Why?
Cell Line, Tumor
3
2010
1403
0.080
Why?
Hepatocytes
2
2008
179
0.080
Why?
Pilot Projects
1
2011
701
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1000
0.080
Why?
Radionuclide Imaging
4
2011
116
0.070
Why?
Hepatitis
1
2008
21
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
29
0.070
Why?
Cytokines
2
2008
607
0.070
Why?
Protons
1
2007
67
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
59
0.070
Why?
Ovariectomy
1
2007
115
0.070
Why?
Organ Size
1
2007
225
0.070
Why?
Oligosaccharides
1
2005
35
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
28
0.060
Why?
Aging
1
2010
694
0.060
Why?
Omentum
1
2005
15
0.060
Why?
Uterine Neoplasms
1
2005
60
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
5
0.060
Why?
Carcinoma, Small Cell
1
2004
25
0.060
Why?
Syndecans
1
2004
35
0.060
Why?
Hematoxylin
1
2004
7
0.060
Why?
Syndecan-1
1
2004
73
0.060
Why?
Endometrium
1
2004
40
0.060
Why?
Immunoenzyme Techniques
1
2004
141
0.060
Why?
Endotoxins
1
2004
31
0.060
Why?
Carbohydrates
1
2004
39
0.060
Why?
Lymphoma, Non-Hodgkin
1
2004
56
0.060
Why?
Liver Diseases, Alcoholic
1
2004
33
0.060
Why?
Pathology
1
2024
38
0.060
Why?
Cytological Techniques
1
2003
14
0.050
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
42
0.050
Why?
Dietary Fats
1
2004
125
0.050
Why?
Fatty Acids
1
2004
145
0.050
Why?
Gene Expression Regulation
1
2008
952
0.050
Why?
Neoplasms
2
2004
1250
0.050
Why?
Malondialdehyde
1
2003
51
0.050
Why?
Gene Expression
2
2019
610
0.050
Why?
Cell Membrane
1
2004
248
0.050
Why?
Aldehydes
1
2003
82
0.050
Why?
Overweight
1
2005
214
0.050
Why?
Risk Factors
1
2011
3733
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
111
0.050
Why?
Surgical Instruments
1
2002
27
0.050
Why?
Breast Diseases
1
2002
26
0.050
Why?
Foreign-Body Migration
1
2002
32
0.050
Why?
Hematoma
3
2010
64
0.050
Why?
Education, Medical, Graduate
1
2024
217
0.050
Why?
Asia
1
2002
19
0.050
Why?
Chronic Disease
1
2004
576
0.050
Why?
Carcinoma, Squamous Cell
1
2004
326
0.050
Why?
Cost-Benefit Analysis
2
2015
269
0.050
Why?
Head and Neck Neoplasms
1
2004
289
0.050
Why?
Time Factors
1
2007
2948
0.040
Why?
Neoplasm Metastasis
2
2015
230
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Health Status
1
2002
300
0.040
Why?
Methyltransferases
1
2019
30
0.040
Why?
Apoptosis
1
2005
1098
0.040
Why?
Disease Progression
2
2015
829
0.040
Why?
Child, Preschool
1
2008
3966
0.040
Why?
Cohort Studies
2
2015
1456
0.040
Why?
Alcohol Dehydrogenase
2
2010
37
0.040
Why?
Oxidative Stress
3
2010
772
0.040
Why?
Anti-Bacterial Agents
1
2004
754
0.040
Why?
Arm
2
2009
47
0.040
Why?
Stereotaxic Techniques
2
2010
38
0.040
Why?
Polymerase Chain Reaction
1
2019
451
0.040
Why?
Risk Assessment
2
2017
1271
0.040
Why?
Disease Models, Animal
2
2015
1440
0.030
Why?
Adiponectin
1
2017
46
0.030
Why?
Reproducibility of Results
2
2015
1199
0.030
Why?
Injections, Intralesional
2
2008
31
0.030
Why?
Feces
1
2017
138
0.030
Why?
Phylogeny
1
2017
237
0.030
Why?
Lipid Metabolism
1
2017
174
0.030
Why?
Leptin
1
2017
142
0.030
Why?
Child
1
2008
6979
0.030
Why?
Cost Savings
1
2015
58
0.030
Why?
Protective Agents
1
2015
16
0.030
Why?
Taxoids
1
2015
37
0.030
Why?
MCF-7 Cells
1
2015
62
0.030
Why?
Mice, Inbred BALB C
2
2005
294
0.030
Why?
Insulin
1
2017
465
0.030
Why?
CpG Islands
1
2015
107
0.030
Why?
Infant, Newborn
1
2002
2760
0.030
Why?
Cyclophosphamide
1
2015
168
0.030
Why?
Tumor Cells, Cultured
1
2015
457
0.030
Why?
Touch
1
2013
25
0.030
Why?
Neoadjuvant Therapy
1
2015
119
0.030
Why?
Biopsy, Large-Core Needle
1
2013
33
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Carcinoma
1
2015
138
0.030
Why?
Infant
1
2002
3660
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
Why?
Radiotherapy, Adjuvant
1
2013
64
0.030
Why?
Hormones
1
2013
57
0.030
Why?
Chemotherapy, Adjuvant
1
2013
121
0.030
Why?
Injections, Intradermal
1
2011
13
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1173
0.020
Why?
United States
1
2002
5012
0.020
Why?
Cicatrix
1
2011
40
0.020
Why?
Intraoperative Period
1
2011
45
0.020
Why?
Diagnosis, Differential
2
2004
1034
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
833
0.020
Why?
Predictive Value of Tests
2
2004
929
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Sulfides
1
2010
28
0.020
Why?
Survival Rate
1
2012
909
0.020
Why?
Chemokines
1
2010
75
0.020
Why?
Double-Blind Method
1
2011
710
0.020
Why?
Transforming Growth Factor beta1
1
2010
60
0.020
Why?
Mammary Glands, Animal
1
2010
69
0.020
Why?
Cell Division
1
2010
294
0.020
Why?
Endoplasmic Reticulum
1
2010
117
0.020
Why?
Pyrazoles
1
2010
112
0.020
Why?
Pregnancy
1
2015
2456
0.020
Why?
Tissue Extracts
1
2007
12
0.020
Why?
Least-Squares Analysis
1
2007
40
0.020
Why?
Enzyme Inhibitors
1
2010
374
0.020
Why?
Biotransformation
1
2007
84
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Survival Analysis
1
2009
661
0.020
Why?
Solubility
1
2007
71
0.020
Why?
Enteral Nutrition
1
2008
150
0.020
Why?
Staining and Labeling
1
2007
97
0.020
Why?
Observer Variation
1
2007
140
0.020
Why?
Positron-Emission Tomography
1
2008
293
0.020
Why?
E-Selectin
1
2005
14
0.020
Why?
Body Weights and Measures
1
2005
17
0.020
Why?
Wheat Germ Agglutinins
1
2005
3
0.020
Why?
Vaccines, Subunit
1
2005
15
0.020
Why?
Vaccines, DNA
1
2005
12
0.020
Why?
Gadolinium
1
2005
45
0.020
Why?
Cross Reactions
1
2005
40
0.020
Why?
Growth Inhibitors
1
2005
27
0.020
Why?
Cytotoxicity, Immunologic
1
2005
57
0.020
Why?
Gene Amplification
1
2005
56
0.010
Why?
Ligands
1
2005
203
0.010
Why?
Mice
2
2005
5677
0.010
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
151
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
231
0.010
Why?
Free Radicals
1
2004
27
0.010
Why?
Sampling Studies
1
2004
36
0.010
Why?
Enzyme Induction
1
2004
79
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Contrast Media
1
2005
191
0.010
Why?
Eye Neoplasms
1
2004
9
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Hyperplasia
1
2004
97
0.010
Why?
Species Specificity
1
2004
187
0.010
Why?
Amino Acid Sequence
1
2005
578
0.010
Why?
Cell Proliferation
1
2008
986
0.010
Why?
Necrosis
1
2004
174
0.010
Why?
Injections
1
2003
58
0.010
Why?
Rats, Wistar
1
2004
223
0.010
Why?
Dietary Carbohydrates
1
2004
91
0.010
Why?
Molecular Sequence Data
1
2005
782
0.010
Why?
Regression Analysis
1
2004
382
0.010
Why?
Cytoplasm
1
2004
92
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
194
0.010
Why?
Energy Intake
1
2004
176
0.010
Why?
Cell Nucleus
1
2004
185
0.010
Why?
Multivariate Analysis
1
2004
584
0.010
Why?
Antigens, Neoplasm
1
2004
148
0.010
Why?
Glutathione
1
2004
299
0.010
Why?
Sex Characteristics
1
2004
199
0.010
Why?
Antioxidants
1
2004
239
0.010
Why?
Confidence Intervals
1
2002
155
0.010
Why?
Models, Theoretical
1
2002
169
0.010
Why?
Neoplasm Proteins
1
2004
321
0.010
Why?
Reoperation
1
2002
462
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description